The loss of radiographic enhancement in primary renal cell carcinoma tumors ... - UroToday PDF Print
UroTodayTo characterize radiographic intratumoral contrast enhancement in the primary tumor of patients with renal cell carcinoma treated with either sorafenib or

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.